The digital therapeutics market is expected to reach US$ 62.29 Billion by 2032.
The digital therapeutics market is expected to grow at a CAGR of 26.9% from 2023 to 2032.
The digital therapeutics market was estimated to be US$ 5.82 billion in 2022.
The key factor driving the growth of the digital therapeutics market is the cost-effectiveness of digital health technology for providers and patients, as well as the increase in smartphone penetration in developed and developing countries.
North America dominates the global digital therapeutics market due to its excellent healthcare infrastructure. The region is expected to experience significant market growth with the increasing prevalence of chronic diseases and technological advancements.
Diabetes is the largest application segment in the digital therapeutics market. This growth is attributed to the rising prevalence of diabetes globally.
Some of the key players in the global digital therapeutics market include Omada Health, Inc., Welldoc, Inc., 2Morrow, Inc., Livongo Health, Inc. (Teladoc Health, Inc.), Propeller Health (ResMed), Fitbit LLC, Canary Health, Noom, Inc., Pear Therapeutics, Inc., Akili Interactive Labs, Inc., Hygieia, DarioHealth Corp., Big Health, Gaia AG, and Limbix Health, Inc.
Copyright © 2023 Same Page Management Consulting Pvt. Ltd. (insightSLICE) | All Rights Reserved